Test systems for diagnosing a new coronavirus
Photo: RIA News. Vitaliy Timkiv
National Technological Initiative (NTI) Company InertGas Medical has developed helium-oxygen mixtures GelOx and medical equipment for their use, which may help to reduce the length of stay of patients on mechanical ventilation, told RIA Novosti the Russian Venture Company's representatives (RVC).
The InertGas Medical project entered the list of 25 NTI projects that were proposed to the Government of the Russian Federation to control coronavirus infection. State registration of the GelOx medicine and a line of medical equipment is scheduled to begin in June.
This medicine is used to reduce the load on the respiratory muscles due to the low density and viscosity of helium. These helium properties are already used in the rehabilitation of patients with chest injuries, intercostal neuralgia, chronic obstructive lung disease, bronchial asthma and other conditions, as noted in the message.
In Russia, the technology for the treatment of helium-oxygen mixtures has been developed since 2001 at the Pulmonary Research Institute of the Ministry of Health of the Russian Federation and has been introduced at the Central Military Clinical Hospital named after N.N. Burdenko under the Ministry of Defense of the Russian Federation. Among the achieved physiological effects — an increase in the main ventilation indicators by 10–12%, a distinct increase of blood oxygenation, perfusion of lung tissue and diffusion capacity of the lungs.